Aquilo Capital Management, LLC
SAN FRANCISCO, CA · CIK 1591986 · 13F filing filed 2022-05-16
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityAQUILO CAPITAL MANAGEMENT, LLC (US)
- Others nearbySan Francisco, CA
$342.6m
reported value
-15.8% vs Q4 2021
12positions
96.0%in top 10
0 new
11 added
0 reduced
1 sold out
vs Q4 2021
Options: 1 call positions ($179.8m notional), 1 put positions ($158.1m notional) – listed below, not included above.
Holdings, Q1 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| BLUEPRINT MEDICINES CORP BPMC | $49.9m14.57% | Added +136.0k |
| ARROWHEAD PHARMACEUTICALS IN ARWR | $48.2m14.06% | Added +347.0k |
| ARVINAS INC ARVN | $46.8m13.66% | Added +131.8k |
| SPERO THERAPEUTICS INC SPRO | $45.9m13.41% | Added +317.3k |
| REGENXBIO INC RGNX | $37.1m10.84% | Added +105.1k |
| MERUS N V MRUS | $33.4m9.74% | Added +365.0k |
| 4D MOLECULAR THERAPEUTICS IN FDMT | $26.5m7.75% | Added +245.6k |
| UNIQURE NV QURE | $16.3m4.76% | Added +225.3k |
| AMRYT PHARMA PLC SPONSORED ADS | $13.6m3.96% | Unchanged |
| PIERIS PHARMACEUTICALS INC COM | $11.2m3.28% | Added +512.4k |
| ARGENX SE ARGX | $7.6m2.21% | Added +1.8k |
| GENMAB A/S GMAB | $6.1m1.77% | Added +40.0k |
Sold out since Q4 2021
| Security | Value then |
|---|---|
| MAGENTA THERAPEUTICS INC | $14.0m3.2m shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| SPDR SER TR XBI · Call | $179.8m2.0m shares | New |
| SPDR S&P 500 ETF TR SPY · Put | $158.1m350.0k shares | Reduced |
Trades reported as a company insider in Q1 2022
Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.
| Date | Company | Trade | Value |
|---|---|---|---|
| 2022-03-30 | SPERO THERAPEUTICS INC 10% owner · See Footnotes | Bought | $439.5k50.0k shares |
| 2022-03-14 | SPERO THERAPEUTICS INC 10% owner · See footnotes | Bought | $119.8k15.7k shares |
| 2022-03-14 | SPERO THERAPEUTICS INC 10% owner · See Footnotes | Bought | $61.1k8.0k shares |
| 2022-02-28 | SPERO THERAPEUTICS INC 10% owner · See Footnotes | Bought | $427.3k44.8k shares |
| 2022-02-18 | SPERO THERAPEUTICS INC 10% owner · See Footnotes | Bought | $137.0k14.8k shares |
| 2022-01-31 | SPERO THERAPEUTICS INC 10% owner · See Footnotes | Bought | $1.4m125.0k shares |
| 2022-01-24 | SPERO THERAPEUTICS INC 10% owner · See Footnotes | Bought | $17.4k1.6k shares |
| 2022-01-18 | SPERO THERAPEUTICS INC 10% owner · See Footnotes | Bought | $601.7k48.5k shares |
| 2022-01-10 | SPERO THERAPEUTICS INC 10% owner · See Footnotes | Bought | $114.7k8.9k shares |